Reported resultsCompany-reported
What was reported
HUDSON, MA, and YOKNEAM ILLIT, Israel, August 14, 2026 – Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today reported financial results for the second quarter ended June 30, 2026.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 14, 2026 · Open the source ↗
What the evidence supports
Lifeward published its results for the period in a press release furnished to the SEC (Form 8-K, Item 2.02).
What remains unknown
Audit status of the figures (results furnished on Form 8-K or 6-K are typically unaudited), and anything about future periods. Any outlook is the company's own projection. Figures and claims are the company's own description and have not been independently verified.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $6.6 million | “• Revenue increased 16% to $6.6 million in the second quarter of 2026 compared to the second quarter of 2025, marking the strongest quarterly revenue performance since the fourth quarter of 2024.” Mentions: revenue |
| $11 million | “• Strengthened the Company's balance sheet to a proforma cash balance of approximately $11 million.” Mentions: cash |
| $9.4 million | “The Company had a cash balance of $9.4 million as of June 30, 2026.” Mentions: cash |
| $11.2 million | “Through a strategic financing closed on July 6, 2026, providing up to $11.2 million in growth capital, Lifeward raised approximately $5.6 million, $4.1 million of which was received during the second quarter, and $1.5 million was received in July.” Mentions: financing |
| $5.6 million | “Through a strategic financing closed on July 6, 2026, providing up to $11.2 million in growth capital, Lifeward raised approximately $5.6 million, $4.1 million of which was received during the second quarter, and $1.5 million was received in July.” Mentions: financing |
| $4.1 million | “Through a strategic financing closed on July 6, 2026, providing up to $11.2 million in growth capital, Lifeward raised approximately $5.6 million, $4.1 million of which was received during the second quarter, and $1.5 million was received in July.” Mentions: financing |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Press release headlineLifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives GrowthU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 14, 2026 · Open the source ↗
Press release lead paragraphHUDSON, MA, and YOKNEAM ILLIT, Israel, August 14, 2026 – Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today reported financial results for the second quarter ended June 30, 2026.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 14, 2026 · Open the source ↗
Amount stated in press release• Revenue increased 16% to $6.6 million in the second quarter of 2026 compared to the second quarter of 2025, marking the strongest quarterly revenue performance since the fourth quarter of 2024.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 14, 2026 · Open the source ↗
Amount stated in press release• Strengthened the Company's balance sheet to a proforma cash balance of approximately $11 million.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 14, 2026 · Open the source ↗
Amount stated in press releaseThe Company had a cash balance of $9.4 million as of June 30, 2026.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 14, 2026 · Open the source ↗
Amount stated in press releaseThrough a strategic financing closed on July 6, 2026, providing up to $11.2 million in growth capital, Lifeward raised approximately $5.6 million, $4.1 million of which was received during the second quarter, and $1.5 million was received in July.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 14, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:53 UTC
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.